West Branch Capital’s Hologic HOLX Stock Holding History

West Branch Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$163	–	584
2024 Q3	$163	Buy	+2	New	+$160	﹤0.01%	486

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

West Branch Capital's HOLX Position: Q4 2024 in Review

West Branch Capital sold out of Hologic (HOLX) in Q4 2024, closing a stake of 2 shares — an estimated $163 sold.

West Branch Capital first reported a position in HOLX in Q3 2024 and held it in 1 quarter. The position peaked at $163 in Q3 2024. 719 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

West Branch Capital reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
West Branch Capital sold 2 Hologic shares in Q4 2024, an estimated $163.
West Branch Capital first reported a position in Hologic in Q3 2024 and held it in 1 quarter.
West Branch Capital's Hologic position peaked at $163 in Q3 2024.
719 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on West Branch Capital's 13F filing for Q4 2024, filed 17 Jan 2025.